focus -WSS

focus

author：fashion 2025-09-06 01:58:22 - browse：61

light shines behind Pfizer CEO Albert Bourla as he attends a ceremony in Greece — Pfizer CEO Albert Bourla Giannis Papanikos/AP

Pfizer has a big problem. The drug giant hopes that new drugs to treat cancer are the solution.

Shares in the drugmaker fell 44% last year, and it now has a market capitalization of only $150 billion — a quarter that of Eli Lilly and half that of longtime rival Merck. In March of last year the company announced that it would spend $43 billion to buy Seagen, a maker of a hot category of oncology medicines called antibody-drug conjugates. Pfizer’s shares have slumped another 9% so far this year. On Thursday, executives are holding an investor briefing to try to convince shareholders that its bet will pay off.

In an interview with STAT, Pfizer CEO Albert Bourla was insistent that the deal’s potential is being missed.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： California Joshua trees severely burned in massive wildfire

hotspot

WSS

There’s a way to spot data fakery. All journals should be using it

Lifetime voting ban for felony convictions struck down in Mississippi

'CMA Fest' 2023: How to watch, who is performing and more

Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal

A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year

What to know about 'Guardians of the Galaxy Vol. 3' as it hits Disney+

hotspot

focus

entertainment

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Taylor Swift shares sweet moment with Kobe Bryant's daughter Bianka at Eras Tour concert

After affirmative action ruling, medical educators look to 'holistic review'

Pharma needs to include young adults in clinical research

Apple is now the first public company to be valued at $3 trillion

Extensive review finds private equity owners jack up cost of care

How one medical school became remarkably diverse

There’s a way to spot data fakery. All journals should be using it

Peter Hotez and the public health issue of online harassment

New company forms to vet health AI models, root out weaknesses

explore

Does Medicare's free annual wellness visit do any good?

Thousands of UK hospital doctors walk out in the latest pay dispute, crippling health services

Caribou posts encouraging results on off

Judge denies Trump's request for new trial in E. Jean Carroll case

Extensive review finds private equity owners jack up cost of care

Eat, drink, but be wary — 4 foods that interact with medications

Wikipedia

hotspot

hotspot

explore